Hedgehog Inhibitors are Effective Treatment for Basal Cell Cancer Recurrence
Journal Title: Journal of Oncology and Cancer Research - Year 2018, Vol 2, Issue 1
Abstract
The hedgehog signaling pathway is one of the major regulators of cell growth and differentiation during embryogenesis. Mutation of some component of hedgehog pathway is common in cancers, especially in basal cell carcinoma (BCC) and Medulloblastoma. Hedgehog inhibitors have recently emerged as a novel treatment for BCC with specific indications and overall clinical benefit. BCC is one of the most common cancers in the United States, comprising approximately 80% of non-melanoma skin cancers. We present a case of an 88 year old female diagnosed with advanced extensive recurrent BCC of scalp whose lesions improved significantly after treatment with Vismodegib despite years of prior neglect.
Authors and Affiliations
Hossein Akhondi
Keywords
Related Articles
- EP ID EP274757
- DOI 10.28967/jocr.2018.01.18002
- Views 114
- Downloads 0
Evaluation of Phosphorylated Proteins Involved in the Epidermal Growth Factor Receptor (EGFR) Signaling Pathway to Predict the Response of Patients with Breast Cancer to Neoadjuvant Chemotherapy Regimens with Weekly Paclitaxel: Preliminary Analysis
This preliminary analysis aimed at evaluating the capacity of epidermal growth factor receptor (EGFR) signaling pathway phosphorylated proteins as predictors of the pathologic response of breast cancer patients treated w...
Appropriate Selection of Segmentectomy for Patients with Early Stage Non-small Cell Lung Cancer
Several randomized-control trials of lung cancer screening, including USA National Lung Cancer Screening Trial (NLST) and Dutch-Belgian Randomized Lung Cancer Screening Trial (NELSON), have explored the value of low-dose...
The Epigenetic Theory of Carcinogenesis: p53 as the Guardian of The Epigenome
The principal advantage of the hypothesis that the multiple phenotypic abnormalities characteristic of malignant and pre-malignant cells result from epigenetic disorder is that it accounts for the wide spectrum of anomal...
Have Cluster Randomised Trials a Role in Health Care Research?
Cluster Randomised trials, where groups of individuals are randomised to different treatments and outcomes measured on individuals, have many limitations inherent in the trial design. Selection bias can be introduced int...
Endothelin Signaling as Target for Anticancer Therapy: from Prostate Cancer to Multiple Myeloma
Neuropeptides including endothelin 1 (ET-1) are potent mitogens for both benign and malignant cells through G-protein receptor binding and signal transduction [1]. Aberrant expression of several components of the endothe...